Why the study?
Digital thermal monitoring of microvascular function is a new and simplified technique correlated with atherosclerosis burden, but microvascular function data in outpatient clinics needed characterization.
What is the frequency of peripheral microvascular dysfunction, as measured by digital thermal monitoring, among US outpatients?
What is the frequency of peripheral microvascular dysfunction, as measured by digital thermal monitoring, among US outpatients?
Peripheral microvascular dysfunction, measured by a simplified digital thermal monitoring technique, is highly prevalent (82%) among US outpatients, potentially indicating high residual cardiovascular risk.
Answers are grounded in this paper and cite their sources.
DTM detects frequent microvascular dysfunction in statin-treated outpatients; leaves open whether it refines residual risk stratification beyond conventional factors.
Previous studies have linked peripheral microvascular dysfunction measured by arterial tonometry to high residual risk in on-statin patients. Digital thermal monitoring (DTM) of microvascular function is a new and simplified technique based on fingertip temperature measurements that has been correlated with the burden of atherosclerosis and its risk factors. Here, we report analyses of DTM data from two large US registries: Registry-I (6,084 cases) and Registry-II (1,021 cases) across 49 US outpatient clinics. DTM tests were performed using a VENDYS device during a 5-minute arm-cuff reactive hyperemia. Fingertip temperature falls during cuff inflation and rebounds after deflation. Adjusted maximum temperature rebound was reported as vascular reactivity index (VRI). VRI distributions were similar in both registries, with <a:math xmlns:a="http://www.w3.org/1998/Math/MathML" id="M1"> <a:mtext>mean</a:mtext> <a:mo>±</a:mo> <a:mtext>SD</a:mtext> </a:math> of <c:math xmlns:c="http://www.w3.org/1998/Math/MathML" id="M2"> <c:mn>1.58</c:mn> <c:mo>±</c:mo> <c:mn>0.53</c:mn> </c:math> in Registry-I and <e:math xmlns:e="http://www.w3.org/1998/Math/MathML" id="M3"> <e:mn>1.52</e:mn> <e:mo>±</e:mo> <e:mn>0.43</e:mn> </e:math> in Registry-II. In the combined dataset, only 18% had optimal VRI (≥2.0) and 82% were either poor (<1.0) or intermediate (1.0-2.0). Women had slightly higher VRI than men ( <g:math xmlns:g="http://www.w3.org/1998/Math/MathML" id="M4"> <g:mn>1.62</g:mn> <g:mo>±</g:mo> <g:mn>0.56</g:mn> </g:math> vs. <i:math xmlns:i="http://www.w3.org/1998/Math/MathML" id="M5"> <i:mn>1.54</i:mn> <i:mo>±</i:mo> <i:mn>0.47</i:mn> </i:math> , <k:math xmlns:k="http://www.w3.org/1998/Math/MathML" id="M6"> <k:mi>p</k:mi> <k:mo><</k:mo> <k:mn>0.001</k:mn> </k:math> ). VRI was inversely but mildly correlated with age ( <m:math xmlns:m="http://www.w3.org/1998/Math/MathML" id="M7"> <m:mi>r</m:mi> <m:mo>=</m:mo> <m:mo>−</m:mo> <m:mn>0.19</m:mn> </m:math> , <o:math xmlns:o="http://www.w3.org/1998/Math/MathML" id="M8"> <o:mi>p</o:mi> <o:mo><</o:mo> <o:mn>0.001</o:mn> </o:math> ). Suboptimal VRI was found in 72% of patients <50 years, 82% of 50-70 years, and 86% of ≥70 years. Blood pressure was not correlated with VRI. In this largest registry of peripheral microvascular function measurements, suboptimal scores were highly frequent among on-treatment patients, possibly suggesting a significant residual risk. Prospective studies are warranted to validate microvascular dysfunction as an indicator of residual risk.
No takes yet. Share an insight, caveat, or question.
Naghavi et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: